A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Pfizer Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 16,952,600 shares of PFE stock, worth $453 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
16,952,600
Previous 17,761,700 4.56%
Holding current value
$453 Million
Previous $497 Million 1.28%
% of portfolio
1.19%
Previous 1.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $22.4 Million - $25.4 Million
-809,100 Reduced 4.56%
16,952,600 $491 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $106 Million - $125 Million
4,214,400 Added 31.11%
17,761,700 $497 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $272 Million - $313 Million
10,524,500 Added 348.17%
13,547,300 $376 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $260 Million - $337 Million
-9,934,301 Reduced 76.67%
3,022,800 $87 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $260 Million - $304 Million
8,109,000 Added 167.26%
12,957,101 $430 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $115 Million - $133 Million
3,172,200 Added 189.28%
4,848,101 $178 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $6.33 Million - $8.24 Million
160,600 Added 10.6%
1,675,901 $68.4 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $60.5 Million - $79 Million
-1,450,200 Reduced 48.9%
1,515,301 $77.7 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $48.5 Million - $59.2 Million
1,107,500 Added 59.61%
2,965,501 $130 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $108 Million - $128 Million
-2,324,100 Reduced 55.57%
1,858,001 $97.4 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $105 Million - $130 Million
-2,301,600 Reduced 35.5%
4,182,101 $217 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $226 Million - $335 Million
5,476,701 Added 543.86%
6,483,701 $383 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $384 Million - $493 Million
-9,778,301 Reduced 90.66%
1,007,000 $43.3 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $3.48 Million - $3.95 Million
97,000 Added 0.91%
10,785,301 $422 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $113 Million - $128 Million
3,383,600 Added 46.32%
10,688,301 $387 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $91.6 Million - $117 Million
-2,738,000 Reduced 27.26%
7,304,701 $269 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $32.5 Million - $38.1 Million
-1,023,800 Reduced 9.25%
10,042,701 $369 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $143 Million - $173 Million
4,736,500 Added 74.83%
11,066,501 $362 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $138 Million - $198 Million
-5,123,700 Reduced 44.73%
6,330,001 $207 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $152 Million - $173 Million
4,625,800 Added 67.75%
11,453,701 $449 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $85.1 Million - $110 Million
2,619,300 Added 62.24%
6,827,901 $245 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $61 Million - $68.5 Million
1,650,601 Added 64.53%
4,208,601 $182 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $513,750 - $564,440
13,700 Added 0.54%
2,558,000 $109 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $12 Million - $13.6 Million
-310,851 Reduced 10.89%
2,544,300 $111 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $38.1 Million - $46.2 Million
-1,105,800 Reduced 27.92%
2,855,151 $126 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $239 Million - $255 Million
-7,261,300 Reduced 64.7%
3,960,951 $144 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $19.4 Million - $22.5 Million
609,100 Added 5.74%
11,222,251 $398 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $24.6 Million - $26.1 Million
740,500 Added 7.5%
10,613,151 $384 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $306 Million - $337 Million
9,872,651
9,872,651 $352 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.